Conbercept Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

Conbercept Market Size

According to new survey, global Conbercept market is projected to reach US$ 273.6 million in 2029, increasing from US$ 167 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2029.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-29M16036/Global_Conbercept_Market_Research_Report_2023

Mechanism of Action: Conbercept is designed to block the activity of vascular endothelial growth factor (VEGF), a protein that plays a crucial role in the development of abnormal blood vessels in the retina. By inhibiting VEGF, Conbercept helps reduce the growth of these abnormal blood vessels.

Administration: Conbercept is typically administered through intravitreal injection, meaning it is injected directly into the eye.

Approved Indications: Conbercept has received regulatory approval in some countries for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and other retinal vascular diseases.

Manufacturer: Conbercept is produced by Chengdu Kanghong Biotech Co., Ltd., a biopharmaceutical company based in China.

Growing Incidence of Retinal Diseases: The prevalence of retinal diseases, such as age-related macular degeneration and diabetic retinopathy, has been increasing globally. This trend has driven the demand for effective treatments like Conbercept.

Expansion of Market Access: Conbercept has gained regulatory approval in several countries, contributing to its market expansion. The availability of Conbercept for patients in different regions has likely influenced market trends.

Competition in the Anti-VEGF Market: The market for anti-VEGF drugs, including Conbercept, is competitive. Other drugs in this class, such as ranibizumab and aflibercept, also play a significant role in the management of retinal diseases.

Research and Development: Ongoing research and development efforts in the field of ophthalmology may lead to the introduction of new therapies or improvements in existing treatments, impacting the market dynamics for Conbercept.

Healthcare Infrastructure and Reimbursement Policies: The accessibility of Conbercept and other similar drugs can be influenced by factors such as healthcare infrastructure, reimbursement policies, and economic considerations in different regions.

By Type
• API
• Preperation

By Application
• nAMD
• pmCNV
• DME

Key Players
Kanghong Pharmaceutical

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-29M16036/global-conbercept

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.